NYSE:EBS
Emergent BioSolutions (EBS)
Financials 
Technical Analysis 
Instead of buying a single vaccine-making pharma, consider this. They have an established vaccine business and are working on plasma-based treatments for Covid. They also have a big contract manufacturing business of vaccines with JNJ, AZN and Novavax. This has fallen $40 from its August peak. But last night they issued bullish future numbers for this year, and the stock jumped 4.7% today. More upside to come.
- «
- ‹
- 1
- ›
- »
Emergent BioSolutions (EBS) Frequently Asked Questions
What is Emergent BioSolutions stock symbol?
Emergent BioSolutions is a American stock, trading under the symbol EBS (previously EBS-N on Stockchase) on the New York Stock Exchange (EBS). It is usually referred to as NYSE:EBS or EBS
Is Emergent BioSolutions a buy or a sell?
In the last year, there was no coverage of Emergent BioSolutions published on Stockchase.
Is Emergent BioSolutions a good investment or a top pick?
Emergent BioSolutions was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Emergent BioSolutions .
Why is Emergent BioSolutions stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
Is Emergent BioSolutions worth watching?
0 stock analysts on Stockchase covered Emergent BioSolutions in the last year. It is a trending stock that is worth watching.
What is Emergent BioSolutions stock price?
On 2026-06-01, Emergent BioSolutions (EBS) stock closed at a price of $8.49.
A disaster. He feels bad for J&J that they ever signed a contract with them.